Intech Biopharm Corporation (TPEX:6461)

Taiwan · Delayed Price · Currency is TWD

24.80

-0.20 (-0.80%)

Nov 13, 2026, 1:30 PM CST

Intech Biopharm Financials Overview

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	54.34	107.53	39.78	25.85	23.65	38.9
Revenue Growth	-52.27%	170.31%	53.90%	9.30%	-39.21%	84.30%
Gross Profit	-192.1	-110.94	-157.63	-164	-147.26	-119.37
Operating Income	-455.72	-364.5	-356.13	-320.47	-318.08	-293.98
Net Income	-474.56	-389.03	-368.21	-337.99	-327.88	-301.76
Earnings Per Share	-4.42	-4.15	-4.34	-4.54	-4.56	-4.80
EPS Growth	-	-	-	-	-	-

Revenue by Geography

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Taiwan	35.89	36.18	21.85	10.61	10.34
China	68.04	-	1.12	9.32	28.23
Hong Kong	1.45	1.83	1.75	0.92	-
Other	2.15	1.77	1.13	2.79	-
Total	107.53	39.78	25.85	23.65	38.9

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	313.68	214.3	258.65	597.73	374.82	335.48
Total Debt	1,600	1,189	1,436	1,435	1,409	1,152
Net Cash (Debt)	-1,286	-974.31	-1,178	-837.33	-1,034	-816.94
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-11.95	-10.39	-13.87	-11.24	-14.39	-12.98

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-312.87	-361.13	-269.22	-204.13	-190.39	-200.61
Capital Expenditures	-38.5	-61.89	-43.62	-30.04	-10.74	-21.31
Free Cash Flow	-351.37	-423.02	-312.84	-234.17	-201.13	-221.91
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	-	-103.18%	-	-	-	-
Operating Margin	-838.60%	-338.99%	-895.26%	-1239.87%	-1345.12%	-755.76%
Pretax Margin	-873.26%	-355.47%	-925.63%	-1307.64%	-1386.55%	-775.74%
Profit Margin	-873.26%	-361.80%	-925.63%	-1307.64%	-1386.55%	-775.74%
FCF Margin	-646.57%	-393.41%	-786.44%	-905.98%	-850.56%	-570.48%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 15, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PS Ratio	50.35	26.97	91.55	158.96	164.45	59.79